Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (629 total)
-
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2022-03-16
Description: This printable flyer infographic "Mind the Gap! Facemask Fit Matters" contains information on mask and masks fit, fitting masks, as maximum mask-to-skin contact is essential.Mind the Gap:Mask Filtration and Fit Matter:Mind the Gap!No matter how well… -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Webinaire
Date de la dernière mise à jour: 2022-01-14
Description: Join us Friday, January 14th, at 12pm CST for the NETEC COVID-19 Webinar Series presentation, Respiratory Protection Program (RPP) for the Non-Acute Healthcare Providers. Topics will include OSHA standards for an effective respiratory protection… -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2022-01-07
Description: The treatment and infection prevention recommendations for influenza and COVID-19 are VERY different. It is important to test and differentiate. This two page graphic provides guidance. -
Créateur: NETEC
Sujet: Infection Control
Type d'élément: Guide
Date de la dernière mise à jour: 2021-12-22
Description: This three page graphic guide explains the differences between the Influenza and COVID-19 viruses. -
Créateur: Marie A de Perio, Chad H Dowell, Lisa J Delaney, Lewis J Radonovich, David T Kuhar, Neil Gupta, Anita Patel, Satish K Pillai, Maryann D'Alessandro
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2020-05-19
Description: N95 respirators are personal protective equipment most often used to control exposures to infections transmitted via the airborne route. Supplies of N95 respirators can become depleted during pandemics or when otherwise in high demand. In this paper,… -
Créateur: CDC
Sujet: Emergency Management
Type d'élément: Guide
Date de la dernière mise à jour: 2020-10-19
Description: The CDC flowchart attached to this page guides you through determining if an N95 FFR Crisis Capacity strategy is needed.Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of…Conservation strategies: This resource contains recommendations facilitating conservation of equipment and supplies during contingency (expected shortages) and crisis (known shortages) capacities and should not be applied as guidance when conventional capacities are available.
-
Créateur: NETEC
Sujet: Emergency Management
Type d'élément: Webinaire
Date de la dernière mise à jour: 2021-11-12
Description: Join us Friday, November 12th, at 12pm CST for the next NETEC COVID-19 Webinar Series presentation, Influenza in the Age of COVID: 2021 Seasonal Update. Join our presenters as they discuss important topics surrounding the upcoming 2021 influenza… -
Créateur: Li, L., L. B. Robinson, R. Patel, A. B. Landman, X. Fu, E. S. Shenoy, D. M. Hashimoto, A. Banerji, P. G. Wickner, U. Samarakoon, C. M. Mancini, Y. Zhang, and K. G. Blumenthal.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-10-01
Description: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after receiving the vaccine are unknown. -
Créateur: Bar-On, Yinon M., Yair Goldberg, Micha Mandel, Omri Bodenheimer, Laurence Freedman, Nir Kalkstein, Barak Mizrahi, Sharon Alroy-Preis, Nachman Ash, Ron Milo, and Amit Huppert.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-10-07
Description: On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5… -
Créateur: the BLAZE-1 Investigators
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-10-07
Description: Patients with underlying medical conditions are at increased risk for severe coronavirus disease 2019 (Covid-19). Whereas vaccine-derived immunity develops over time, neutralizing monoclonal-antibody treatment provides immediate, passive immunity and…